1. Home
  2. MUX vs OGN Comparison

MUX vs OGN Comparison

Compare MUX & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

HOLD

Current Price

$21.39

Market Cap

1.6B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.14

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUX
OGN
Founded
1979
1923
Country
Canada
United States
Employees
1432
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MUX
OGN
Price
$21.39
$6.14
Analyst Decision
Strong Buy
Hold
Analyst Count
4
4
Target Price
$26.63
$11.75
AVG Volume (30 Days)
988.1K
3.0M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
1.34%
EPS Growth
N/A
N/A
EPS
N/A
0.72
Revenue
N/A
$6,216,000,000.00
Revenue This Year
$22.52
$0.42
Revenue Next Year
$26.24
$1.67
P/E Ratio
N/A
$8.31
Revenue Growth
N/A
N/A
52 Week Low
$6.38
$5.69
52 Week High
$29.70
$14.70

Technical Indicators

Market Signals
Indicator
MUX
OGN
Relative Strength Index (RSI) 47.99 39.63
Support Level $17.91 N/A
Resistance Level $26.94 $7.87
Average True Range (ATR) 1.23 0.24
MACD 0.03 0.03
Stochastic Oscillator 52.12 51.79

Price Performance

Historical Comparison
MUX
OGN

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: